Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study

Rodolfo Savica, Thomas G. Beach, Joseph G. Hentz, Marwan N. Sabbagh, Geidy E. Serrano, Lucia I. Sue, Brittany Dugger, Holly A. Shill, Erika Driver-Dunckley, John N. Caviness, Shyamal H. Mehta, Sandra A. Jacobson, Christine M. Belden, Kathryn J. Davis, Edward Zamrini, David R. Shprecher, Charles H. Adler

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Identify clinical features predictive of Lewy body pathology in Alzheimer's disease (AD) patients in an ongoing longitudinal clinicopathologic study. Material and Methods: We queried the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) database for dementia cases with AD pathology (1997-2015). Subjects received longitudinal comprehensive clinical evaluations including motor/neuropsychological assessment and Apo-E4 genotyping. All cases were autopsied and had standard neuropathological assessments for AD and Lewy-type synucleinopathy (LTS). Subjects were categorized based on standardized pathological criteria with AD cases that had LTS but did not meet DLB pathologic criteria being categorized as ADLB. We performed pairwise comparison between the different diagnoses and multivariable modelling to identify clinical symptoms that predict the pathological diagnosis. Results: We identified 32 DLB/AD, 54 ADLB, 70 AD only and 41 PDD/AD cases. AD subjects with LTS pathology had higher UPDRS II and III total scores as well as generally higher individual scores compared to AD alone. While depression scales and Trail-making Test A correlated significantly with LTS, other neuropsychological variables were not significantly different. Apo E4 occurrence was similar in all groups (40%-49%). Conclusions: Our study suggests that the presence (or absence) of LTS influences motor and non-motor clinical findings in AD patients. These findings may lead to biomarkers that allow for more targeted treatment of AD.

Original languageEnglish (US)
JournalActa Neurologica Scandinavica
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Lewy Bodies
Alzheimer Disease
Prospective Studies
Pathology
Apolipoprotein E4
Trail Making Test
Neurodegenerative Diseases
Longitudinal Studies
Dementia
Biomarkers

Keywords

  • Alzheimer's disease
  • Lewy bodies
  • neuropsychology
  • pathology

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Savica, R., Beach, T. G., Hentz, J. G., Sabbagh, M. N., Serrano, G. E., Sue, L. I., ... Adler, C. H. (Accepted/In press). Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.13028

Lewy body pathology in Alzheimer's disease : A clinicopathological prospective study. / Savica, Rodolfo; Beach, Thomas G.; Hentz, Joseph G.; Sabbagh, Marwan N.; Serrano, Geidy E.; Sue, Lucia I.; Dugger, Brittany; Shill, Holly A.; Driver-Dunckley, Erika; Caviness, John N.; Mehta, Shyamal H.; Jacobson, Sandra A.; Belden, Christine M.; Davis, Kathryn J.; Zamrini, Edward; Shprecher, David R.; Adler, Charles H.

In: Acta Neurologica Scandinavica, 01.01.2018.

Research output: Contribution to journalArticle

Savica, R, Beach, TG, Hentz, JG, Sabbagh, MN, Serrano, GE, Sue, LI, Dugger, B, Shill, HA, Driver-Dunckley, E, Caviness, JN, Mehta, SH, Jacobson, SA, Belden, CM, Davis, KJ, Zamrini, E, Shprecher, DR & Adler, CH 2018, 'Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study', Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.13028
Savica, Rodolfo ; Beach, Thomas G. ; Hentz, Joseph G. ; Sabbagh, Marwan N. ; Serrano, Geidy E. ; Sue, Lucia I. ; Dugger, Brittany ; Shill, Holly A. ; Driver-Dunckley, Erika ; Caviness, John N. ; Mehta, Shyamal H. ; Jacobson, Sandra A. ; Belden, Christine M. ; Davis, Kathryn J. ; Zamrini, Edward ; Shprecher, David R. ; Adler, Charles H. / Lewy body pathology in Alzheimer's disease : A clinicopathological prospective study. In: Acta Neurologica Scandinavica. 2018.
@article{721c920147824d2896a7d6c9b377396e,
title = "Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study",
abstract = "Objective: Identify clinical features predictive of Lewy body pathology in Alzheimer's disease (AD) patients in an ongoing longitudinal clinicopathologic study. Material and Methods: We queried the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) database for dementia cases with AD pathology (1997-2015). Subjects received longitudinal comprehensive clinical evaluations including motor/neuropsychological assessment and Apo-E4 genotyping. All cases were autopsied and had standard neuropathological assessments for AD and Lewy-type synucleinopathy (LTS). Subjects were categorized based on standardized pathological criteria with AD cases that had LTS but did not meet DLB pathologic criteria being categorized as ADLB. We performed pairwise comparison between the different diagnoses and multivariable modelling to identify clinical symptoms that predict the pathological diagnosis. Results: We identified 32 DLB/AD, 54 ADLB, 70 AD only and 41 PDD/AD cases. AD subjects with LTS pathology had higher UPDRS II and III total scores as well as generally higher individual scores compared to AD alone. While depression scales and Trail-making Test A correlated significantly with LTS, other neuropsychological variables were not significantly different. Apo E4 occurrence was similar in all groups (40{\%}-49{\%}). Conclusions: Our study suggests that the presence (or absence) of LTS influences motor and non-motor clinical findings in AD patients. These findings may lead to biomarkers that allow for more targeted treatment of AD.",
keywords = "Alzheimer's disease, Lewy bodies, neuropsychology, pathology",
author = "Rodolfo Savica and Beach, {Thomas G.} and Hentz, {Joseph G.} and Sabbagh, {Marwan N.} and Serrano, {Geidy E.} and Sue, {Lucia I.} and Brittany Dugger and Shill, {Holly A.} and Erika Driver-Dunckley and Caviness, {John N.} and Mehta, {Shyamal H.} and Jacobson, {Sandra A.} and Belden, {Christine M.} and Davis, {Kathryn J.} and Edward Zamrini and Shprecher, {David R.} and Adler, {Charles H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ane.13028",
language = "English (US)",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Lewy body pathology in Alzheimer's disease

T2 - A clinicopathological prospective study

AU - Savica, Rodolfo

AU - Beach, Thomas G.

AU - Hentz, Joseph G.

AU - Sabbagh, Marwan N.

AU - Serrano, Geidy E.

AU - Sue, Lucia I.

AU - Dugger, Brittany

AU - Shill, Holly A.

AU - Driver-Dunckley, Erika

AU - Caviness, John N.

AU - Mehta, Shyamal H.

AU - Jacobson, Sandra A.

AU - Belden, Christine M.

AU - Davis, Kathryn J.

AU - Zamrini, Edward

AU - Shprecher, David R.

AU - Adler, Charles H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Identify clinical features predictive of Lewy body pathology in Alzheimer's disease (AD) patients in an ongoing longitudinal clinicopathologic study. Material and Methods: We queried the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) database for dementia cases with AD pathology (1997-2015). Subjects received longitudinal comprehensive clinical evaluations including motor/neuropsychological assessment and Apo-E4 genotyping. All cases were autopsied and had standard neuropathological assessments for AD and Lewy-type synucleinopathy (LTS). Subjects were categorized based on standardized pathological criteria with AD cases that had LTS but did not meet DLB pathologic criteria being categorized as ADLB. We performed pairwise comparison between the different diagnoses and multivariable modelling to identify clinical symptoms that predict the pathological diagnosis. Results: We identified 32 DLB/AD, 54 ADLB, 70 AD only and 41 PDD/AD cases. AD subjects with LTS pathology had higher UPDRS II and III total scores as well as generally higher individual scores compared to AD alone. While depression scales and Trail-making Test A correlated significantly with LTS, other neuropsychological variables were not significantly different. Apo E4 occurrence was similar in all groups (40%-49%). Conclusions: Our study suggests that the presence (or absence) of LTS influences motor and non-motor clinical findings in AD patients. These findings may lead to biomarkers that allow for more targeted treatment of AD.

AB - Objective: Identify clinical features predictive of Lewy body pathology in Alzheimer's disease (AD) patients in an ongoing longitudinal clinicopathologic study. Material and Methods: We queried the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) database for dementia cases with AD pathology (1997-2015). Subjects received longitudinal comprehensive clinical evaluations including motor/neuropsychological assessment and Apo-E4 genotyping. All cases were autopsied and had standard neuropathological assessments for AD and Lewy-type synucleinopathy (LTS). Subjects were categorized based on standardized pathological criteria with AD cases that had LTS but did not meet DLB pathologic criteria being categorized as ADLB. We performed pairwise comparison between the different diagnoses and multivariable modelling to identify clinical symptoms that predict the pathological diagnosis. Results: We identified 32 DLB/AD, 54 ADLB, 70 AD only and 41 PDD/AD cases. AD subjects with LTS pathology had higher UPDRS II and III total scores as well as generally higher individual scores compared to AD alone. While depression scales and Trail-making Test A correlated significantly with LTS, other neuropsychological variables were not significantly different. Apo E4 occurrence was similar in all groups (40%-49%). Conclusions: Our study suggests that the presence (or absence) of LTS influences motor and non-motor clinical findings in AD patients. These findings may lead to biomarkers that allow for more targeted treatment of AD.

KW - Alzheimer's disease

KW - Lewy bodies

KW - neuropsychology

KW - pathology

UR - http://www.scopus.com/inward/record.url?scp=85054594972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054594972&partnerID=8YFLogxK

U2 - 10.1111/ane.13028

DO - 10.1111/ane.13028

M3 - Article

C2 - 30229861

AN - SCOPUS:85054594972

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

ER -